Collegium Pharmaceutical, Inc. (COLL) NASDAQ
30.48
-1.3(-4.09%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
30.48
-1.3(-4.09%)
Currency In USD
| Market Cap | 1.47B |
| Enterprise Value | 2.16B |
| P/E Ratio | 13.05 |
| PEG Ratio | 0.19 |
| Price/Sales Ratio | 1.24 |
| Price/Book Ratio | 3.13 |
| Enterprise/Revenue | 1.92 |
| Enterprise/EBITDA | 2.52 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0.09 |
| Operating Margin | 0.24 |
| Return On Assets | 0.05 |
| Return On Equity | 0.27 |
| Revenue | 780.57M |
| Revenue/Share | 24.82 |
| Gross Profit | 463.26M |
| EBITDA | 401.01M |
| Net Income | 62.87M |
| Diluted EPS | 1.73 |
| Total Cash | 421.75M |
| Total Cash/Share | 13.14 |
| Total Debt | 808.06M |
| Total Debt/Equity | 2.59 |
| Current Ratio | 1.71 |
| Book Value Per Share | 9.74 |
| 52-Week Change | 3.99 |
| 52-Week High | 50.79 |
| 52-Week Low | 29.08 |
| Moving Average 50 Days | 33.98 |
| Moving Average 200 Days | 39.6 |
| Average Volume | 530,109 |
| Shares Outstanding | 32.43M |
| % Held by Institutions | 118.86 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |